Global Liquid Tumor Biopsy Market Research Report 2025(Status and Outlook)
Report Overview
Liquid tumor biopsy refers to a non-invasive diagnostic technique that analyzes circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), exosomes, and other biomarkers present in bodily fluids such as blood, urine, or cerebrospinal fluid to detect and monitor cancer. Unlike traditional tissue biopsies, which require surgical extraction of tumor samples, liquid biopsies offer a less invasive alternative, enabling real-time monitoring of tumor dynamics, treatment response, and resistance mutations. This technology is particularly valuable for cancers that are difficult to access or in cases where repeated tissue sampling is impractical. Liquid biopsies are increasingly used in oncology for early cancer detection, personalized treatment selection, minimal residual disease monitoring, and tracking clonal evolution, making them a transformative tool in precision medicine.
The global liquid biopsy market is experiencing rapid growth, driven by increasing cancer prevalence, advancements in next-generation sequencing (NGS), and the demand for less invasive diagnostic methods. Key applications include lung, breast, colorectal, and prostate cancers, with ctDNA-based tests dominating the market due to their high sensitivity and clinical utility. Major players like Guardant Health, Roche, Illumina, and Bio-Rad are investing heavily in research and commercialization, while regulatory approvals for companion diagnostics further accelerate adoption. However, challenges such as standardization, cost, and limited reimbursement policies in some regions hinder widespread implementation. North America leads the market due to strong healthcare infrastructure and early adoption of innovative technologies, while Asia-Pacific shows the fastest growth due to rising cancer incidence and improving diagnostic capabilities. Emerging trends include multi-analyte liquid biopsies, AI-driven data interpretation, and expanding applications in immunotherapy monitoring. The market is projected to expand significantly as liquid biopsies become integral to cancer care, supported by ongoing clinical validation and integration with precision oncology frameworks.
The global Liquid Tumor Biopsy market size was estimated at USD 1001.35 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 15.50% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Liquid Tumor Biopsy market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Liquid Tumor Biopsy market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Liquid Tumor Biopsy market.
Global Liquid Tumor Biopsy Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Abbott Laboratories
Bio-Rad Laboratories
F. Hoffmann-La Roche
Illumina
QIAGEN N.V.
Thermo Fisher Scientific
Amoy Diagnostics
HaploX
Whole Genome Sequencing
Burning Rock Biotech
Market Segmentation (by Type)
ctDNA
CTC
Market Segmentation (by Application)
Clinical Laboratories
Hospital
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Liquid Tumor Biopsy Market
Overview of the regional outlook of the Liquid Tumor Biopsy Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Liquid Tumor Biopsy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Liquid Tumor Biopsy, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Liquid tumor biopsy refers to a non-invasive diagnostic technique that analyzes circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), exosomes, and other biomarkers present in bodily fluids such as blood, urine, or cerebrospinal fluid to detect and monitor cancer. Unlike traditional tissue biopsies, which require surgical extraction of tumor samples, liquid biopsies offer a less invasive alternative, enabling real-time monitoring of tumor dynamics, treatment response, and resistance mutations. This technology is particularly valuable for cancers that are difficult to access or in cases where repeated tissue sampling is impractical. Liquid biopsies are increasingly used in oncology for early cancer detection, personalized treatment selection, minimal residual disease monitoring, and tracking clonal evolution, making them a transformative tool in precision medicine.
The global liquid biopsy market is experiencing rapid growth, driven by increasing cancer prevalence, advancements in next-generation sequencing (NGS), and the demand for less invasive diagnostic methods. Key applications include lung, breast, colorectal, and prostate cancers, with ctDNA-based tests dominating the market due to their high sensitivity and clinical utility. Major players like Guardant Health, Roche, Illumina, and Bio-Rad are investing heavily in research and commercialization, while regulatory approvals for companion diagnostics further accelerate adoption. However, challenges such as standardization, cost, and limited reimbursement policies in some regions hinder widespread implementation. North America leads the market due to strong healthcare infrastructure and early adoption of innovative technologies, while Asia-Pacific shows the fastest growth due to rising cancer incidence and improving diagnostic capabilities. Emerging trends include multi-analyte liquid biopsies, AI-driven data interpretation, and expanding applications in immunotherapy monitoring. The market is projected to expand significantly as liquid biopsies become integral to cancer care, supported by ongoing clinical validation and integration with precision oncology frameworks.
The global Liquid Tumor Biopsy market size was estimated at USD 1001.35 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 15.50% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Liquid Tumor Biopsy market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Liquid Tumor Biopsy market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Liquid Tumor Biopsy market.
Global Liquid Tumor Biopsy Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Abbott Laboratories
Bio-Rad Laboratories
F. Hoffmann-La Roche
Illumina
QIAGEN N.V.
Thermo Fisher Scientific
Amoy Diagnostics
HaploX
Whole Genome Sequencing
Burning Rock Biotech
Market Segmentation (by Type)
ctDNA
CTC
Market Segmentation (by Application)
Clinical Laboratories
Hospital
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Liquid Tumor Biopsy Market
Overview of the regional outlook of the Liquid Tumor Biopsy Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Liquid Tumor Biopsy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Liquid Tumor Biopsy, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Liquid Tumor Biopsy
1.2 Key Market Segments
1.2.1 Liquid Tumor Biopsy Segment by Type
1.2.2 Liquid Tumor Biopsy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 LIQUID TUMOR BIOPSY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Liquid Tumor Biopsy Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Liquid Tumor Biopsy Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 LIQUID TUMOR BIOPSY MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Liquid Tumor Biopsy Product Life Cycle
3.3 Global Liquid Tumor Biopsy Sales by Manufacturers (2020-2025)
3.4 Global Liquid Tumor Biopsy Revenue Market Share by Manufacturers (2020-2025)
3.5 Liquid Tumor Biopsy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Liquid Tumor Biopsy Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Liquid Tumor Biopsy Market Competitive Situation and Trends
3.8.1 Liquid Tumor Biopsy Market Concentration Rate
3.8.2 Global 5 and 10 Largest Liquid Tumor Biopsy Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 LIQUID TUMOR BIOPSY INDUSTRY CHAIN ANALYSIS
4.1 Liquid Tumor Biopsy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF LIQUID TUMOR BIOPSY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Liquid Tumor Biopsy Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Liquid Tumor Biopsy Market
5.7 ESG Ratings of Leading Companies
6 LIQUID TUMOR BIOPSY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Liquid Tumor Biopsy Sales Market Share by Type (2020-2025)
6.3 Global Liquid Tumor Biopsy Market Size Market Share by Type (2020-2025)
6.4 Global Liquid Tumor Biopsy Price by Type (2020-2025)
7 LIQUID TUMOR BIOPSY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Liquid Tumor Biopsy Market Sales by Application (2020-2025)
7.3 Global Liquid Tumor Biopsy Market Size (M USD) by Application (2020-2025)
7.4 Global Liquid Tumor Biopsy Sales Growth Rate by Application (2020-2025)
8 LIQUID TUMOR BIOPSY MARKET SALES BY REGION
8.1 Global Liquid Tumor Biopsy Sales by Region
8.1.1 Global Liquid Tumor Biopsy Sales by Region
8.1.2 Global Liquid Tumor Biopsy Sales Market Share by Region
8.2 Global Liquid Tumor Biopsy Market Size by Region
8.2.1 Global Liquid Tumor Biopsy Market Size by Region
8.2.2 Global Liquid Tumor Biopsy Market Size Market Share by Region
8.3 North America
8.3.1 North America Liquid Tumor Biopsy Sales by Country
8.3.2 North America Liquid Tumor Biopsy Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Liquid Tumor Biopsy Sales by Country
8.4.2 Europe Liquid Tumor Biopsy Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Liquid Tumor Biopsy Sales by Region
8.5.2 Asia Pacific Liquid Tumor Biopsy Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Liquid Tumor Biopsy Sales by Country
8.6.2 South America Liquid Tumor Biopsy Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Liquid Tumor Biopsy Sales by Region
8.7.2 Middle East and Africa Liquid Tumor Biopsy Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 LIQUID TUMOR BIOPSY MARKET PRODUCTION BY REGION
9.1 Global Production of Liquid Tumor Biopsy by Region(2020-2025)
9.2 Global Liquid Tumor Biopsy Revenue Market Share by Region (2020-2025)
9.3 Global Liquid Tumor Biopsy Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Liquid Tumor Biopsy Production
9.4.1 North America Liquid Tumor Biopsy Production Growth Rate (2020-2025)
9.4.2 North America Liquid Tumor Biopsy Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Liquid Tumor Biopsy Production
9.5.1 Europe Liquid Tumor Biopsy Production Growth Rate (2020-2025)
9.5.2 Europe Liquid Tumor Biopsy Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Liquid Tumor Biopsy Production (2020-2025)
9.6.1 Japan Liquid Tumor Biopsy Production Growth Rate (2020-2025)
9.6.2 Japan Liquid Tumor Biopsy Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Liquid Tumor Biopsy Production (2020-2025)
9.7.1 China Liquid Tumor Biopsy Production Growth Rate (2020-2025)
9.7.2 China Liquid Tumor Biopsy Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Abbott Laboratories
10.1.1 Abbott Laboratories Basic Information
10.1.2 Abbott Laboratories Liquid Tumor Biopsy Product Overview
10.1.3 Abbott Laboratories Liquid Tumor Biopsy Product Market Performance
10.1.4 Abbott Laboratories Business Overview
10.1.5 Abbott Laboratories SWOT Analysis
10.1.6 Abbott Laboratories Recent Developments
10.2 Bio-Rad Laboratories
10.2.1 Bio-Rad Laboratories Basic Information
10.2.2 Bio-Rad Laboratories Liquid Tumor Biopsy Product Overview
10.2.3 Bio-Rad Laboratories Liquid Tumor Biopsy Product Market Performance
10.2.4 Bio-Rad Laboratories Business Overview
10.2.5 Bio-Rad Laboratories SWOT Analysis
10.2.6 Bio-Rad Laboratories Recent Developments
10.3 F. Hoffmann-La Roche
10.3.1 F. Hoffmann-La Roche Basic Information
10.3.2 F. Hoffmann-La Roche Liquid Tumor Biopsy Product Overview
10.3.3 F. Hoffmann-La Roche Liquid Tumor Biopsy Product Market Performance
10.3.4 F. Hoffmann-La Roche Business Overview
10.3.5 F. Hoffmann-La Roche SWOT Analysis
10.3.6 F. Hoffmann-La Roche Recent Developments
10.4 Illumina
10.4.1 Illumina Basic Information
10.4.2 Illumina Liquid Tumor Biopsy Product Overview
10.4.3 Illumina Liquid Tumor Biopsy Product Market Performance
10.4.4 Illumina Business Overview
10.4.5 Illumina Recent Developments
10.5 QIAGEN N.V.
10.5.1 QIAGEN N.V. Basic Information
10.5.2 QIAGEN N.V. Liquid Tumor Biopsy Product Overview
10.5.3 QIAGEN N.V. Liquid Tumor Biopsy Product Market Performance
10.5.4 QIAGEN N.V. Business Overview
10.5.5 QIAGEN N.V. Recent Developments
10.6 Thermo Fisher Scientific
10.6.1 Thermo Fisher Scientific Basic Information
10.6.2 Thermo Fisher Scientific Liquid Tumor Biopsy Product Overview
10.6.3 Thermo Fisher Scientific Liquid Tumor Biopsy Product Market Performance
10.6.4 Thermo Fisher Scientific Business Overview
10.6.5 Thermo Fisher Scientific Recent Developments
10.7 Amoy Diagnostics
10.7.1 Amoy Diagnostics Basic Information
10.7.2 Amoy Diagnostics Liquid Tumor Biopsy Product Overview
10.7.3 Amoy Diagnostics Liquid Tumor Biopsy Product Market Performance
10.7.4 Amoy Diagnostics Business Overview
10.7.5 Amoy Diagnostics Recent Developments
10.8 HaploX
10.8.1 HaploX Basic Information
10.8.2 HaploX Liquid Tumor Biopsy Product Overview
10.8.3 HaploX Liquid Tumor Biopsy Product Market Performance
10.8.4 HaploX Business Overview
10.8.5 HaploX Recent Developments
10.9 Whole Genome Sequencing
10.9.1 Whole Genome Sequencing Basic Information
10.9.2 Whole Genome Sequencing Liquid Tumor Biopsy Product Overview
10.9.3 Whole Genome Sequencing Liquid Tumor Biopsy Product Market Performance
10.9.4 Whole Genome Sequencing Business Overview
10.9.5 Whole Genome Sequencing Recent Developments
10.10 Burning Rock Biotech
10.10.1 Burning Rock Biotech Basic Information
10.10.2 Burning Rock Biotech Liquid Tumor Biopsy Product Overview
10.10.3 Burning Rock Biotech Liquid Tumor Biopsy Product Market Performance
10.10.4 Burning Rock Biotech Business Overview
10.10.5 Burning Rock Biotech Recent Developments
11 LIQUID TUMOR BIOPSY MARKET FORECAST BY REGION
11.1 Global Liquid Tumor Biopsy Market Size Forecast
11.2 Global Liquid Tumor Biopsy Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Liquid Tumor Biopsy Market Size Forecast by Country
11.2.3 Asia Pacific Liquid Tumor Biopsy Market Size Forecast by Region
11.2.4 South America Liquid Tumor Biopsy Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Liquid Tumor Biopsy by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Liquid Tumor Biopsy Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Liquid Tumor Biopsy by Type (2026-2033)
12.1.2 Global Liquid Tumor Biopsy Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Liquid Tumor Biopsy by Type (2026-2033)
12.2 Global Liquid Tumor Biopsy Market Forecast by Application (2026-2033)
12.2.1 Global Liquid Tumor Biopsy Sales (K Units) Forecast by Application
12.2.2 Global Liquid Tumor Biopsy Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Liquid Tumor Biopsy
1.2 Key Market Segments
1.2.1 Liquid Tumor Biopsy Segment by Type
1.2.2 Liquid Tumor Biopsy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 LIQUID TUMOR BIOPSY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Liquid Tumor Biopsy Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Liquid Tumor Biopsy Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 LIQUID TUMOR BIOPSY MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Liquid Tumor Biopsy Product Life Cycle
3.3 Global Liquid Tumor Biopsy Sales by Manufacturers (2020-2025)
3.4 Global Liquid Tumor Biopsy Revenue Market Share by Manufacturers (2020-2025)
3.5 Liquid Tumor Biopsy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Liquid Tumor Biopsy Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Liquid Tumor Biopsy Market Competitive Situation and Trends
3.8.1 Liquid Tumor Biopsy Market Concentration Rate
3.8.2 Global 5 and 10 Largest Liquid Tumor Biopsy Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 LIQUID TUMOR BIOPSY INDUSTRY CHAIN ANALYSIS
4.1 Liquid Tumor Biopsy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF LIQUID TUMOR BIOPSY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Liquid Tumor Biopsy Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Liquid Tumor Biopsy Market
5.7 ESG Ratings of Leading Companies
6 LIQUID TUMOR BIOPSY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Liquid Tumor Biopsy Sales Market Share by Type (2020-2025)
6.3 Global Liquid Tumor Biopsy Market Size Market Share by Type (2020-2025)
6.4 Global Liquid Tumor Biopsy Price by Type (2020-2025)
7 LIQUID TUMOR BIOPSY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Liquid Tumor Biopsy Market Sales by Application (2020-2025)
7.3 Global Liquid Tumor Biopsy Market Size (M USD) by Application (2020-2025)
7.4 Global Liquid Tumor Biopsy Sales Growth Rate by Application (2020-2025)
8 LIQUID TUMOR BIOPSY MARKET SALES BY REGION
8.1 Global Liquid Tumor Biopsy Sales by Region
8.1.1 Global Liquid Tumor Biopsy Sales by Region
8.1.2 Global Liquid Tumor Biopsy Sales Market Share by Region
8.2 Global Liquid Tumor Biopsy Market Size by Region
8.2.1 Global Liquid Tumor Biopsy Market Size by Region
8.2.2 Global Liquid Tumor Biopsy Market Size Market Share by Region
8.3 North America
8.3.1 North America Liquid Tumor Biopsy Sales by Country
8.3.2 North America Liquid Tumor Biopsy Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Liquid Tumor Biopsy Sales by Country
8.4.2 Europe Liquid Tumor Biopsy Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Liquid Tumor Biopsy Sales by Region
8.5.2 Asia Pacific Liquid Tumor Biopsy Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Liquid Tumor Biopsy Sales by Country
8.6.2 South America Liquid Tumor Biopsy Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Liquid Tumor Biopsy Sales by Region
8.7.2 Middle East and Africa Liquid Tumor Biopsy Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 LIQUID TUMOR BIOPSY MARKET PRODUCTION BY REGION
9.1 Global Production of Liquid Tumor Biopsy by Region(2020-2025)
9.2 Global Liquid Tumor Biopsy Revenue Market Share by Region (2020-2025)
9.3 Global Liquid Tumor Biopsy Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Liquid Tumor Biopsy Production
9.4.1 North America Liquid Tumor Biopsy Production Growth Rate (2020-2025)
9.4.2 North America Liquid Tumor Biopsy Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Liquid Tumor Biopsy Production
9.5.1 Europe Liquid Tumor Biopsy Production Growth Rate (2020-2025)
9.5.2 Europe Liquid Tumor Biopsy Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Liquid Tumor Biopsy Production (2020-2025)
9.6.1 Japan Liquid Tumor Biopsy Production Growth Rate (2020-2025)
9.6.2 Japan Liquid Tumor Biopsy Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Liquid Tumor Biopsy Production (2020-2025)
9.7.1 China Liquid Tumor Biopsy Production Growth Rate (2020-2025)
9.7.2 China Liquid Tumor Biopsy Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Abbott Laboratories
10.1.1 Abbott Laboratories Basic Information
10.1.2 Abbott Laboratories Liquid Tumor Biopsy Product Overview
10.1.3 Abbott Laboratories Liquid Tumor Biopsy Product Market Performance
10.1.4 Abbott Laboratories Business Overview
10.1.5 Abbott Laboratories SWOT Analysis
10.1.6 Abbott Laboratories Recent Developments
10.2 Bio-Rad Laboratories
10.2.1 Bio-Rad Laboratories Basic Information
10.2.2 Bio-Rad Laboratories Liquid Tumor Biopsy Product Overview
10.2.3 Bio-Rad Laboratories Liquid Tumor Biopsy Product Market Performance
10.2.4 Bio-Rad Laboratories Business Overview
10.2.5 Bio-Rad Laboratories SWOT Analysis
10.2.6 Bio-Rad Laboratories Recent Developments
10.3 F. Hoffmann-La Roche
10.3.1 F. Hoffmann-La Roche Basic Information
10.3.2 F. Hoffmann-La Roche Liquid Tumor Biopsy Product Overview
10.3.3 F. Hoffmann-La Roche Liquid Tumor Biopsy Product Market Performance
10.3.4 F. Hoffmann-La Roche Business Overview
10.3.5 F. Hoffmann-La Roche SWOT Analysis
10.3.6 F. Hoffmann-La Roche Recent Developments
10.4 Illumina
10.4.1 Illumina Basic Information
10.4.2 Illumina Liquid Tumor Biopsy Product Overview
10.4.3 Illumina Liquid Tumor Biopsy Product Market Performance
10.4.4 Illumina Business Overview
10.4.5 Illumina Recent Developments
10.5 QIAGEN N.V.
10.5.1 QIAGEN N.V. Basic Information
10.5.2 QIAGEN N.V. Liquid Tumor Biopsy Product Overview
10.5.3 QIAGEN N.V. Liquid Tumor Biopsy Product Market Performance
10.5.4 QIAGEN N.V. Business Overview
10.5.5 QIAGEN N.V. Recent Developments
10.6 Thermo Fisher Scientific
10.6.1 Thermo Fisher Scientific Basic Information
10.6.2 Thermo Fisher Scientific Liquid Tumor Biopsy Product Overview
10.6.3 Thermo Fisher Scientific Liquid Tumor Biopsy Product Market Performance
10.6.4 Thermo Fisher Scientific Business Overview
10.6.5 Thermo Fisher Scientific Recent Developments
10.7 Amoy Diagnostics
10.7.1 Amoy Diagnostics Basic Information
10.7.2 Amoy Diagnostics Liquid Tumor Biopsy Product Overview
10.7.3 Amoy Diagnostics Liquid Tumor Biopsy Product Market Performance
10.7.4 Amoy Diagnostics Business Overview
10.7.5 Amoy Diagnostics Recent Developments
10.8 HaploX
10.8.1 HaploX Basic Information
10.8.2 HaploX Liquid Tumor Biopsy Product Overview
10.8.3 HaploX Liquid Tumor Biopsy Product Market Performance
10.8.4 HaploX Business Overview
10.8.5 HaploX Recent Developments
10.9 Whole Genome Sequencing
10.9.1 Whole Genome Sequencing Basic Information
10.9.2 Whole Genome Sequencing Liquid Tumor Biopsy Product Overview
10.9.3 Whole Genome Sequencing Liquid Tumor Biopsy Product Market Performance
10.9.4 Whole Genome Sequencing Business Overview
10.9.5 Whole Genome Sequencing Recent Developments
10.10 Burning Rock Biotech
10.10.1 Burning Rock Biotech Basic Information
10.10.2 Burning Rock Biotech Liquid Tumor Biopsy Product Overview
10.10.3 Burning Rock Biotech Liquid Tumor Biopsy Product Market Performance
10.10.4 Burning Rock Biotech Business Overview
10.10.5 Burning Rock Biotech Recent Developments
11 LIQUID TUMOR BIOPSY MARKET FORECAST BY REGION
11.1 Global Liquid Tumor Biopsy Market Size Forecast
11.2 Global Liquid Tumor Biopsy Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Liquid Tumor Biopsy Market Size Forecast by Country
11.2.3 Asia Pacific Liquid Tumor Biopsy Market Size Forecast by Region
11.2.4 South America Liquid Tumor Biopsy Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Liquid Tumor Biopsy by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Liquid Tumor Biopsy Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Liquid Tumor Biopsy by Type (2026-2033)
12.1.2 Global Liquid Tumor Biopsy Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Liquid Tumor Biopsy by Type (2026-2033)
12.2 Global Liquid Tumor Biopsy Market Forecast by Application (2026-2033)
12.2.1 Global Liquid Tumor Biopsy Sales (K Units) Forecast by Application
12.2.2 Global Liquid Tumor Biopsy Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Liquid Tumor Biopsy Market Size Comparison by Region (M USD)
Table 5. Global Liquid Tumor Biopsy Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Liquid Tumor Biopsy Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Liquid Tumor Biopsy Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Liquid Tumor Biopsy Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liquid Tumor Biopsy as of 2024)
Table 10. Global Market Liquid Tumor Biopsy Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Liquid Tumor Biopsy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Liquid Tumor Biopsy Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Liquid Tumor Biopsy Sales by Type (K Units)
Table 26. Global Liquid Tumor Biopsy Market Size by Type (M USD)
Table 27. Global Liquid Tumor Biopsy Sales (K Units) by Type (2020-2025)
Table 28. Global Liquid Tumor Biopsy Sales Market Share by Type (2020-2025)
Table 29. Global Liquid Tumor Biopsy Market Size (M USD) by Type (2020-2025)
Table 30. Global Liquid Tumor Biopsy Market Size Share by Type (2020-2025)
Table 31. Global Liquid Tumor Biopsy Price (USD/Unit) by Type (2020-2025)
Table 32. Global Liquid Tumor Biopsy Sales (K Units) by Application
Table 33. Global Liquid Tumor Biopsy Market Size by Application
Table 34. Global Liquid Tumor Biopsy Sales by Application (2020-2025) & (K Units)
Table 35. Global Liquid Tumor Biopsy Sales Market Share by Application (2020-2025)
Table 36. Global Liquid Tumor Biopsy Market Size by Application (2020-2025) & (M USD)
Table 37. Global Liquid Tumor Biopsy Market Share by Application (2020-2025)
Table 38. Global Liquid Tumor Biopsy Sales Growth Rate by Application (2020-2025)
Table 39. Global Liquid Tumor Biopsy Sales by Region (2020-2025) & (K Units)
Table 40. Global Liquid Tumor Biopsy Sales Market Share by Region (2020-2025)
Table 41. Global Liquid Tumor Biopsy Market Size by Region (2020-2025) & (M USD)
Table 42. Global Liquid Tumor Biopsy Market Size Market Share by Region (2020-2025)
Table 43. North America Liquid Tumor Biopsy Sales by Country (2020-2025) & (K Units)
Table 44. North America Liquid Tumor Biopsy Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Liquid Tumor Biopsy Sales by Country (2020-2025) & (K Units)
Table 46. Europe Liquid Tumor Biopsy Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Liquid Tumor Biopsy Sales by Region (2020-2025) & (K Units)
Table 48. Asia Pacific Liquid Tumor Biopsy Market Size by Region (2020-2025) & (M USD)
Table 49. South America Liquid Tumor Biopsy Sales by Country (2020-2025) & (K Units)
Table 50. South America Liquid Tumor Biopsy Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Liquid Tumor Biopsy Sales by Region (2020-2025) & (K Units)
Table 52. Middle East and Africa Liquid Tumor Biopsy Market Size by Region (2020-2025) & (M USD)
Table 53. Global Liquid Tumor Biopsy Production (K Units) by Region(2020-2025)
Table 54. Global Liquid Tumor Biopsy Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Liquid Tumor Biopsy Revenue Market Share by Region (2020-2025)
Table 56. Global Liquid Tumor Biopsy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. North America Liquid Tumor Biopsy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Europe Liquid Tumor Biopsy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Japan Liquid Tumor Biopsy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. China Liquid Tumor Biopsy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. Abbott Laboratories Basic Information
Table 62. Abbott Laboratories Liquid Tumor Biopsy Product Overview
Table 63. Abbott Laboratories Liquid Tumor Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. Abbott Laboratories Business Overview
Table 65. Abbott Laboratories SWOT Analysis
Table 66. Abbott Laboratories Recent Developments
Table 67. Bio-Rad Laboratories Basic Information
Table 68. Bio-Rad Laboratories Liquid Tumor Biopsy Product Overview
Table 69. Bio-Rad Laboratories Liquid Tumor Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 70. Bio-Rad Laboratories Business Overview
Table 71. Bio-Rad Laboratories SWOT Analysis
Table 72. Bio-Rad Laboratories Recent Developments
Table 73. F. Hoffmann-La Roche Basic Information
Table 74. F. Hoffmann-La Roche Liquid Tumor Biopsy Product Overview
Table 75. F. Hoffmann-La Roche Liquid Tumor Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. F. Hoffmann-La Roche Business Overview
Table 77. F. Hoffmann-La Roche SWOT Analysis
Table 78. F. Hoffmann-La Roche Recent Developments
Table 79. Illumina Basic Information
Table 80. Illumina Liquid Tumor Biopsy Product Overview
Table 81. Illumina Liquid Tumor Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Illumina Business Overview
Table 83. Illumina Recent Developments
Table 84. QIAGEN N.V. Basic Information
Table 85. QIAGEN N.V. Liquid Tumor Biopsy Product Overview
Table 86. QIAGEN N.V. Liquid Tumor Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. QIAGEN N.V. Business Overview
Table 88. QIAGEN N.V. Recent Developments
Table 89. Thermo Fisher Scientific Basic Information
Table 90. Thermo Fisher Scientific Liquid Tumor Biopsy Product Overview
Table 91. Thermo Fisher Scientific Liquid Tumor Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Thermo Fisher Scientific Business Overview
Table 93. Thermo Fisher Scientific Recent Developments
Table 94. Amoy Diagnostics Basic Information
Table 95. Amoy Diagnostics Liquid Tumor Biopsy Product Overview
Table 96. Amoy Diagnostics Liquid Tumor Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Amoy Diagnostics Business Overview
Table 98. Amoy Diagnostics Recent Developments
Table 99. HaploX Basic Information
Table 100. HaploX Liquid Tumor Biopsy Product Overview
Table 101. HaploX Liquid Tumor Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. HaploX Business Overview
Table 103. HaploX Recent Developments
Table 104. Whole Genome Sequencing Basic Information
Table 105. Whole Genome Sequencing Liquid Tumor Biopsy Product Overview
Table 106. Whole Genome Sequencing Liquid Tumor Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. Whole Genome Sequencing Business Overview
Table 108. Whole Genome Sequencing Recent Developments
Table 109. Burning Rock Biotech Basic Information
Table 110. Burning Rock Biotech Liquid Tumor Biopsy Product Overview
Table 111. Burning Rock Biotech Liquid Tumor Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. Burning Rock Biotech Business Overview
Table 113. Burning Rock Biotech Recent Developments
Table 114. Global Liquid Tumor Biopsy Sales Forecast by Region (2026-2033) & (K Units)
Table 115. Global Liquid Tumor Biopsy Market Size Forecast by Region (2026-2033) & (M USD)
Table 116. North America Liquid Tumor Biopsy Sales Forecast by Country (2026-2033) & (K Units)
Table 117. North America Liquid Tumor Biopsy Market Size Forecast by Country (2026-2033) & (M USD)
Table 118. Europe Liquid Tumor Biopsy Sales Forecast by Country (2026-2033) & (K Units)
Table 119. Europe Liquid Tumor Biopsy Market Size Forecast by Country (2026-2033) & (M USD)
Table 120. Asia Pacific Liquid Tumor Biopsy Sales Forecast by Region (2026-2033) & (K Units)
Table 121. Asia Pacific Liquid Tumor Biopsy Market Size Forecast by Region (2026-2033) & (M USD)
Table 122. South America Liquid Tumor Biopsy Sales Forecast by Country (2026-2033) & (K Units)
Table 123. South America Liquid Tumor Biopsy Market Size Forecast by Country (2026-2033) & (M USD)
Table 124. Middle East and Africa Liquid Tumor Biopsy Sales Forecast by Country (2026-2033) & (Units)
Table 125. Middle East and Africa Liquid Tumor Biopsy Market Size Forecast by Country (2026-2033) & (M USD)
Table 126. Global Liquid Tumor Biopsy Sales Forecast by Type (2026-2033) & (K Units)
Table 127. Global Liquid Tumor Biopsy Market Size Forecast by Type (2026-2033) & (M USD)
Table 128. Global Liquid Tumor Biopsy Price Forecast by Type (2026-2033) & (USD/Unit)
Table 129. Global Liquid Tumor Biopsy Sales (K Units) Forecast by Application (2026-2033)
Table 130. Global Liquid Tumor Biopsy Market Size Forecast by Application (2026-2033) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Liquid Tumor Biopsy Market Size Comparison by Region (M USD)
Table 5. Global Liquid Tumor Biopsy Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Liquid Tumor Biopsy Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Liquid Tumor Biopsy Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Liquid Tumor Biopsy Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liquid Tumor Biopsy as of 2024)
Table 10. Global Market Liquid Tumor Biopsy Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Liquid Tumor Biopsy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Liquid Tumor Biopsy Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Liquid Tumor Biopsy Sales by Type (K Units)
Table 26. Global Liquid Tumor Biopsy Market Size by Type (M USD)
Table 27. Global Liquid Tumor Biopsy Sales (K Units) by Type (2020-2025)
Table 28. Global Liquid Tumor Biopsy Sales Market Share by Type (2020-2025)
Table 29. Global Liquid Tumor Biopsy Market Size (M USD) by Type (2020-2025)
Table 30. Global Liquid Tumor Biopsy Market Size Share by Type (2020-2025)
Table 31. Global Liquid Tumor Biopsy Price (USD/Unit) by Type (2020-2025)
Table 32. Global Liquid Tumor Biopsy Sales (K Units) by Application
Table 33. Global Liquid Tumor Biopsy Market Size by Application
Table 34. Global Liquid Tumor Biopsy Sales by Application (2020-2025) & (K Units)
Table 35. Global Liquid Tumor Biopsy Sales Market Share by Application (2020-2025)
Table 36. Global Liquid Tumor Biopsy Market Size by Application (2020-2025) & (M USD)
Table 37. Global Liquid Tumor Biopsy Market Share by Application (2020-2025)
Table 38. Global Liquid Tumor Biopsy Sales Growth Rate by Application (2020-2025)
Table 39. Global Liquid Tumor Biopsy Sales by Region (2020-2025) & (K Units)
Table 40. Global Liquid Tumor Biopsy Sales Market Share by Region (2020-2025)
Table 41. Global Liquid Tumor Biopsy Market Size by Region (2020-2025) & (M USD)
Table 42. Global Liquid Tumor Biopsy Market Size Market Share by Region (2020-2025)
Table 43. North America Liquid Tumor Biopsy Sales by Country (2020-2025) & (K Units)
Table 44. North America Liquid Tumor Biopsy Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Liquid Tumor Biopsy Sales by Country (2020-2025) & (K Units)
Table 46. Europe Liquid Tumor Biopsy Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Liquid Tumor Biopsy Sales by Region (2020-2025) & (K Units)
Table 48. Asia Pacific Liquid Tumor Biopsy Market Size by Region (2020-2025) & (M USD)
Table 49. South America Liquid Tumor Biopsy Sales by Country (2020-2025) & (K Units)
Table 50. South America Liquid Tumor Biopsy Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Liquid Tumor Biopsy Sales by Region (2020-2025) & (K Units)
Table 52. Middle East and Africa Liquid Tumor Biopsy Market Size by Region (2020-2025) & (M USD)
Table 53. Global Liquid Tumor Biopsy Production (K Units) by Region(2020-2025)
Table 54. Global Liquid Tumor Biopsy Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Liquid Tumor Biopsy Revenue Market Share by Region (2020-2025)
Table 56. Global Liquid Tumor Biopsy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. North America Liquid Tumor Biopsy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Europe Liquid Tumor Biopsy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Japan Liquid Tumor Biopsy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. China Liquid Tumor Biopsy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. Abbott Laboratories Basic Information
Table 62. Abbott Laboratories Liquid Tumor Biopsy Product Overview
Table 63. Abbott Laboratories Liquid Tumor Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. Abbott Laboratories Business Overview
Table 65. Abbott Laboratories SWOT Analysis
Table 66. Abbott Laboratories Recent Developments
Table 67. Bio-Rad Laboratories Basic Information
Table 68. Bio-Rad Laboratories Liquid Tumor Biopsy Product Overview
Table 69. Bio-Rad Laboratories Liquid Tumor Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 70. Bio-Rad Laboratories Business Overview
Table 71. Bio-Rad Laboratories SWOT Analysis
Table 72. Bio-Rad Laboratories Recent Developments
Table 73. F. Hoffmann-La Roche Basic Information
Table 74. F. Hoffmann-La Roche Liquid Tumor Biopsy Product Overview
Table 75. F. Hoffmann-La Roche Liquid Tumor Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. F. Hoffmann-La Roche Business Overview
Table 77. F. Hoffmann-La Roche SWOT Analysis
Table 78. F. Hoffmann-La Roche Recent Developments
Table 79. Illumina Basic Information
Table 80. Illumina Liquid Tumor Biopsy Product Overview
Table 81. Illumina Liquid Tumor Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Illumina Business Overview
Table 83. Illumina Recent Developments
Table 84. QIAGEN N.V. Basic Information
Table 85. QIAGEN N.V. Liquid Tumor Biopsy Product Overview
Table 86. QIAGEN N.V. Liquid Tumor Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. QIAGEN N.V. Business Overview
Table 88. QIAGEN N.V. Recent Developments
Table 89. Thermo Fisher Scientific Basic Information
Table 90. Thermo Fisher Scientific Liquid Tumor Biopsy Product Overview
Table 91. Thermo Fisher Scientific Liquid Tumor Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Thermo Fisher Scientific Business Overview
Table 93. Thermo Fisher Scientific Recent Developments
Table 94. Amoy Diagnostics Basic Information
Table 95. Amoy Diagnostics Liquid Tumor Biopsy Product Overview
Table 96. Amoy Diagnostics Liquid Tumor Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Amoy Diagnostics Business Overview
Table 98. Amoy Diagnostics Recent Developments
Table 99. HaploX Basic Information
Table 100. HaploX Liquid Tumor Biopsy Product Overview
Table 101. HaploX Liquid Tumor Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. HaploX Business Overview
Table 103. HaploX Recent Developments
Table 104. Whole Genome Sequencing Basic Information
Table 105. Whole Genome Sequencing Liquid Tumor Biopsy Product Overview
Table 106. Whole Genome Sequencing Liquid Tumor Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. Whole Genome Sequencing Business Overview
Table 108. Whole Genome Sequencing Recent Developments
Table 109. Burning Rock Biotech Basic Information
Table 110. Burning Rock Biotech Liquid Tumor Biopsy Product Overview
Table 111. Burning Rock Biotech Liquid Tumor Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. Burning Rock Biotech Business Overview
Table 113. Burning Rock Biotech Recent Developments
Table 114. Global Liquid Tumor Biopsy Sales Forecast by Region (2026-2033) & (K Units)
Table 115. Global Liquid Tumor Biopsy Market Size Forecast by Region (2026-2033) & (M USD)
Table 116. North America Liquid Tumor Biopsy Sales Forecast by Country (2026-2033) & (K Units)
Table 117. North America Liquid Tumor Biopsy Market Size Forecast by Country (2026-2033) & (M USD)
Table 118. Europe Liquid Tumor Biopsy Sales Forecast by Country (2026-2033) & (K Units)
Table 119. Europe Liquid Tumor Biopsy Market Size Forecast by Country (2026-2033) & (M USD)
Table 120. Asia Pacific Liquid Tumor Biopsy Sales Forecast by Region (2026-2033) & (K Units)
Table 121. Asia Pacific Liquid Tumor Biopsy Market Size Forecast by Region (2026-2033) & (M USD)
Table 122. South America Liquid Tumor Biopsy Sales Forecast by Country (2026-2033) & (K Units)
Table 123. South America Liquid Tumor Biopsy Market Size Forecast by Country (2026-2033) & (M USD)
Table 124. Middle East and Africa Liquid Tumor Biopsy Sales Forecast by Country (2026-2033) & (Units)
Table 125. Middle East and Africa Liquid Tumor Biopsy Market Size Forecast by Country (2026-2033) & (M USD)
Table 126. Global Liquid Tumor Biopsy Sales Forecast by Type (2026-2033) & (K Units)
Table 127. Global Liquid Tumor Biopsy Market Size Forecast by Type (2026-2033) & (M USD)
Table 128. Global Liquid Tumor Biopsy Price Forecast by Type (2026-2033) & (USD/Unit)
Table 129. Global Liquid Tumor Biopsy Sales (K Units) Forecast by Application (2026-2033)
Table 130. Global Liquid Tumor Biopsy Market Size Forecast by Application (2026-2033) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Liquid Tumor Biopsy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Liquid Tumor Biopsy Market Size (M USD), 2024-2033
Figure 5. Global Liquid Tumor Biopsy Market Size (M USD) (2020-2033)
Figure 6. Global Liquid Tumor Biopsy Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Liquid Tumor Biopsy Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Liquid Tumor Biopsy Product Life Cycle
Figure 13. Liquid Tumor Biopsy Sales Share by Manufacturers in 2024
Figure 14. Global Liquid Tumor Biopsy Revenue Share by Manufacturers in 2024
Figure 15. Liquid Tumor Biopsy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Liquid Tumor Biopsy Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Liquid Tumor Biopsy Revenue in 2024
Figure 18. Industry Chain Map of Liquid Tumor Biopsy
Figure 19. Global Liquid Tumor Biopsy Market PEST Analysis
Figure 20. Global Liquid Tumor Biopsy Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Liquid Tumor Biopsy Market Share by Type
Figure 27. Sales Market Share of Liquid Tumor Biopsy by Type (2020-2025)
Figure 28. Sales Market Share of Liquid Tumor Biopsy by Type in 2024
Figure 29. Market Size Share of Liquid Tumor Biopsy by Type (2020-2025)
Figure 30. Market Size Share of Liquid Tumor Biopsy by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Liquid Tumor Biopsy Market Share by Application
Figure 33. Global Liquid Tumor Biopsy Sales Market Share by Application (2020-2025)
Figure 34. Global Liquid Tumor Biopsy Sales Market Share by Application in 2024
Figure 35. Global Liquid Tumor Biopsy Market Share by Application (2020-2025)
Figure 36. Global Liquid Tumor Biopsy Market Share by Application in 2024
Figure 37. Global Liquid Tumor Biopsy Sales Growth Rate by Application (2020-2025)
Figure 38. Global Liquid Tumor Biopsy Sales Market Share by Region (2020-2025)
Figure 39. Global Liquid Tumor Biopsy Market Size Market Share by Region (2020-2025)
Figure 40. North America Liquid Tumor Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Liquid Tumor Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Liquid Tumor Biopsy Sales Market Share by Country in 2024
Figure 43. North America Liquid Tumor Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Liquid Tumor Biopsy Market Size Market Share by Country in 2024
Figure 45. U.S. Liquid Tumor Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Liquid Tumor Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Liquid Tumor Biopsy Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Liquid Tumor Biopsy Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Liquid Tumor Biopsy Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Liquid Tumor Biopsy Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Liquid Tumor Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Liquid Tumor Biopsy Sales Market Share by Country in 2024
Figure 53. Europe Liquid Tumor Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Liquid Tumor Biopsy Market Size Market Share by Country in 2024
Figure 55. Germany Liquid Tumor Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Liquid Tumor Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Liquid Tumor Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Liquid Tumor Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Liquid Tumor Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Liquid Tumor Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Liquid Tumor Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Liquid Tumor Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Liquid Tumor Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Liquid Tumor Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Liquid Tumor Biopsy Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Liquid Tumor Biopsy Sales Market Share by Region in 2024
Figure 67. Asia Pacific Liquid Tumor Biopsy Market Size Market Share by Region in 2024
Figure 68. China Liquid Tumor Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Liquid Tumor Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Liquid Tumor Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Liquid Tumor Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Liquid Tumor Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Liquid Tumor Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Liquid Tumor Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Liquid Tumor Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Liquid Tumor Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Liquid Tumor Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Liquid Tumor Biopsy Sales and Growth Rate (K Units)
Figure 79. South America Liquid Tumor Biopsy Sales Market Share by Country in 2024
Figure 80. South America Liquid Tumor Biopsy Market Size and Growth Rate (M USD)
Figure 81. South America Liquid Tumor Biopsy Market Size Market Share by Country in 2024
Figure 82. Brazil Liquid Tumor Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Liquid Tumor Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Liquid Tumor Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Liquid Tumor Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Liquid Tumor Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Liquid Tumor Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Liquid Tumor Biopsy Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Liquid Tumor Biopsy Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Liquid Tumor Biopsy Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Liquid Tumor Biopsy Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Liquid Tumor Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Liquid Tumor Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Liquid Tumor Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Liquid Tumor Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Liquid Tumor Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Liquid Tumor Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Liquid Tumor Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Liquid Tumor Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Liquid Tumor Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Liquid Tumor Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Liquid Tumor Biopsy Production Market Share by Region (2020-2025)
Figure 103. North America Liquid Tumor Biopsy Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Liquid Tumor Biopsy Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Liquid Tumor Biopsy Production (K Units) Growth Rate (2020-2025)
Figure 106. China Liquid Tumor Biopsy Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Liquid Tumor Biopsy Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global Liquid Tumor Biopsy Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Liquid Tumor Biopsy Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Liquid Tumor Biopsy Market Share Forecast by Type (2026-2033)
Figure 111. Global Liquid Tumor Biopsy Sales Forecast by Application (2026-2033)
Figure 112. Global Liquid Tumor Biopsy Market Share Forecast by Application (2026-2033)
Figure 1. Product Picture of Liquid Tumor Biopsy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Liquid Tumor Biopsy Market Size (M USD), 2024-2033
Figure 5. Global Liquid Tumor Biopsy Market Size (M USD) (2020-2033)
Figure 6. Global Liquid Tumor Biopsy Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Liquid Tumor Biopsy Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Liquid Tumor Biopsy Product Life Cycle
Figure 13. Liquid Tumor Biopsy Sales Share by Manufacturers in 2024
Figure 14. Global Liquid Tumor Biopsy Revenue Share by Manufacturers in 2024
Figure 15. Liquid Tumor Biopsy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Liquid Tumor Biopsy Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Liquid Tumor Biopsy Revenue in 2024
Figure 18. Industry Chain Map of Liquid Tumor Biopsy
Figure 19. Global Liquid Tumor Biopsy Market PEST Analysis
Figure 20. Global Liquid Tumor Biopsy Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Liquid Tumor Biopsy Market Share by Type
Figure 27. Sales Market Share of Liquid Tumor Biopsy by Type (2020-2025)
Figure 28. Sales Market Share of Liquid Tumor Biopsy by Type in 2024
Figure 29. Market Size Share of Liquid Tumor Biopsy by Type (2020-2025)
Figure 30. Market Size Share of Liquid Tumor Biopsy by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Liquid Tumor Biopsy Market Share by Application
Figure 33. Global Liquid Tumor Biopsy Sales Market Share by Application (2020-2025)
Figure 34. Global Liquid Tumor Biopsy Sales Market Share by Application in 2024
Figure 35. Global Liquid Tumor Biopsy Market Share by Application (2020-2025)
Figure 36. Global Liquid Tumor Biopsy Market Share by Application in 2024
Figure 37. Global Liquid Tumor Biopsy Sales Growth Rate by Application (2020-2025)
Figure 38. Global Liquid Tumor Biopsy Sales Market Share by Region (2020-2025)
Figure 39. Global Liquid Tumor Biopsy Market Size Market Share by Region (2020-2025)
Figure 40. North America Liquid Tumor Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Liquid Tumor Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Liquid Tumor Biopsy Sales Market Share by Country in 2024
Figure 43. North America Liquid Tumor Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Liquid Tumor Biopsy Market Size Market Share by Country in 2024
Figure 45. U.S. Liquid Tumor Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Liquid Tumor Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Liquid Tumor Biopsy Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Liquid Tumor Biopsy Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Liquid Tumor Biopsy Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Liquid Tumor Biopsy Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Liquid Tumor Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Liquid Tumor Biopsy Sales Market Share by Country in 2024
Figure 53. Europe Liquid Tumor Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Liquid Tumor Biopsy Market Size Market Share by Country in 2024
Figure 55. Germany Liquid Tumor Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Liquid Tumor Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Liquid Tumor Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Liquid Tumor Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Liquid Tumor Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Liquid Tumor Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Liquid Tumor Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Liquid Tumor Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Liquid Tumor Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Liquid Tumor Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Liquid Tumor Biopsy Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Liquid Tumor Biopsy Sales Market Share by Region in 2024
Figure 67. Asia Pacific Liquid Tumor Biopsy Market Size Market Share by Region in 2024
Figure 68. China Liquid Tumor Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Liquid Tumor Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Liquid Tumor Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Liquid Tumor Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Liquid Tumor Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Liquid Tumor Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Liquid Tumor Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Liquid Tumor Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Liquid Tumor Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Liquid Tumor Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Liquid Tumor Biopsy Sales and Growth Rate (K Units)
Figure 79. South America Liquid Tumor Biopsy Sales Market Share by Country in 2024
Figure 80. South America Liquid Tumor Biopsy Market Size and Growth Rate (M USD)
Figure 81. South America Liquid Tumor Biopsy Market Size Market Share by Country in 2024
Figure 82. Brazil Liquid Tumor Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Liquid Tumor Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Liquid Tumor Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Liquid Tumor Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Liquid Tumor Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Liquid Tumor Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Liquid Tumor Biopsy Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Liquid Tumor Biopsy Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Liquid Tumor Biopsy Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Liquid Tumor Biopsy Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Liquid Tumor Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Liquid Tumor Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Liquid Tumor Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Liquid Tumor Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Liquid Tumor Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Liquid Tumor Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Liquid Tumor Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Liquid Tumor Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Liquid Tumor Biopsy Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Liquid Tumor Biopsy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Liquid Tumor Biopsy Production Market Share by Region (2020-2025)
Figure 103. North America Liquid Tumor Biopsy Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Liquid Tumor Biopsy Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Liquid Tumor Biopsy Production (K Units) Growth Rate (2020-2025)
Figure 106. China Liquid Tumor Biopsy Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Liquid Tumor Biopsy Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global Liquid Tumor Biopsy Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Liquid Tumor Biopsy Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Liquid Tumor Biopsy Market Share Forecast by Type (2026-2033)
Figure 111. Global Liquid Tumor Biopsy Sales Forecast by Application (2026-2033)
Figure 112. Global Liquid Tumor Biopsy Market Share Forecast by Application (2026-2033)
